Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
CoreMap logo — You have to 'see' AF to treat AF.

CoreMap

You have to 'see' AF to treat AF.

Founded 2016 United States Burlington, United States 39 employees Series B Total: $33.75M Biotechnology, Health Care +1

General Information

Company Name CoreMap
Founded Year 2016
Location United States Burlington, United States +2
Founders / Decision Makers
Team member
Employees 39
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series B
Social

Get notified when CoreMap moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CoreMap

CoreMap is a biotechnology and health care startup that is focused on improving patient outcomes by providing advanced diagnostic technology to electrophysiologists and patients. The company's slogan, "You have to 'see' AF to treat AF," underscores their commitment to developing patient-specific treatments for the 33 million individuals suffering from atrial fibrillation. This approach recognizes that a one-size-fits-all solution does not suffice for such a diverse patient population. Having been established in 2016 and headquartered in the United States, CoreMap recently secured a significant $3.00M Series A investment on 09 February 2022. The company's expansion is further evident in their active recruitment efforts across various departments, as they seek talented individuals to contribute to their mission. Furthermore, for those interested in career opportunities with CoreMap, they can explore current job openings by contacting [email protected]. As a venture capital analyst, it is notable that CoreMap's recent funding round signifies investor confidence in the company's vision and technological advancements. This injection of capital is critical as the startup progresses in its mission to revolutionize cardiac care. Moreover, the emphasis on tailored treatments and the potential to address a substantial patient population make CoreMap an intriguing prospect for those seeking investment opportunities in the ever-evolving health tech sector.

Taxonomy: Medical Device, Cardiac mapping, Electrophysiology, Cardiology, Innovation, Atrial fibrillation, Arrhythmia, Medtech

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 3
Investor
•••• •••• 		09 Feb 2022
Series A •••••• - 09 Feb 2022
Series A •••••• 2
Investor
•••• •••• 		16 Sep 2020
Grant •••••• 1
Investor
26 Aug 2020

CoreMap Alternatives & Competitors

CoreMap vs
Curae
Curae United States

Financial Access for All Patients

16 employees
Finance, Financial Services
CoreMap vs
Red Spot Interactive
Red Spot Interactive United States

The patient engagement CRM for medical practices.

25 employees
Analytics, Big Data
Compare CoreMap vs Red Spot Interactive
CoreMap vs
Emento
Emento Denmark

Unlock the patient’s resources to drive positive change in healthcare

30 employees
IT, Information Technology
Compare CoreMap vs Emento
Also compare with: CoreMap vs Adit Adit

FAQ About CoreMap

You have to 'see' AF to treat AF.
CoreMap was founded in 2016.
CoreMap is headquartered in Burlington, United States.
CoreMap operates in the following industries: Biotechnology, Health Care, Medical Devices.
CoreMap has approximately 39 employees.
CoreMap has completed 4 funding rounds, raising a total of $33.75M. The latest funding stage is Series B.
Top alternatives and competitors to CoreMap include Curae, Red Spot Interactive, Emento, Adit, HFA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CoreMap and Curae are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CoreMap and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes